Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth

Jeddar, 1985, The antibacterial action of honey: an in vitro study, S. Afr. Med. J., 67, 257 Hladon, 1980, In vitro studies on the cytostatic activity of propolis extracts, Arzneim.-Forsch. Drug Res., 30, 1847 Koshihara, 1984, Caffeic acid is a selective inhibitor for leukotriene biosynthesis, Biochim. Biophys. Acta., 792, 92, 10.1016/0005-2760(84)90287-X Greenaway, 1987, The analysis of bud exudate of Populus x euramericana and of propolis by gas chromatography-mass spectrometry, B232, 249 Grunberger, 1988, Preferential cytotoxicity of tumor cells by caffeic acid phenethyl ester isolated from propolis, Experientia, 44, 230, 10.1007/BF01941717 Wattenberg, 1985, Chemoprevention of cancer, Cancer Res., 45, 1 Watteberg, 1980, Inhibitory effects of phenolic compounds on Benzo(a)pyrene-induced neoplasia, Cancer Res., 40, 2820 Hayase, 1984, Antioxidative compounds of sweet potatoes, J. Nutr. Sci Vitaminol., 30, 37, 10.3177/jnsv.30.37 Das, 1984, Plant phenols as in vitro inhibitors of glutathione S-transferase(s), Biochem. Biophys. Res. Commun., 127, 427, 10.1016/0006-291X(84)91271-3 Heby, 1981, Role of polyamines in the control of cell proliferation and differentiation, Differentiation, 19, 1, 10.1111/j.1432-0436.1981.tb01123.x Russell, 1978, Polyamines as biochemical markers of normal and malignant growth, Prog. Cancer Res. Ther., 8, 1 Takano, 1981, Early induction of rat colonic epithelia ornithine and S-adenosyl-1-methionine decarboxylase activities by N-methyl-N′-nitro-N-nitroguanidine or bile salts, Cancer Res., 41, 624 Pegg, 1988, Polyamine metabolism and its importance in neoplastic growth asa target for chemotherapy, Cancer Res., 48, 759 Hunter, 1985, Protein tyrosine kinases, Annu. Rev. Biochem., 54, 897, 10.1146/annurev.bi.54.070185.004341 Giordano, 1987, Protein phosphorylated on tyrosine as markers of human tumor cell lines, Int. J. Cancer, 38, 482, 10.1002/ijc.2910390413 Powis, 1991, Signalling targets for anticancer drug development, Trends in Pharmacol. Sci., 12, 188, 10.1016/0165-6147(91)90545-4 Gazit, 1991, Tyrphostins 2. Heterocyclic and α-substituted benzylidenemalanonitrile tyrphostins as potent inhibitors of EGF receptor and Erb B2/new Tyrosine kinases, J. Med. Chem., 34, 1896, 10.1021/jm00110a022 Helferich, 1935, Esters of caffeic acid, J. Prakt. Chem., 142, 191, 10.1002/prac.19351420606 Hashimoto, 1988, Synthesis of two allergenic constituents of propolis and polar bud excreations, Naturoforsch., c: Bio Sci., 43, 470, 10.1515/znc-1988-5-625 Maron, 1983, Revised methods for the Salmonella mutagenicity test, Mutat. Res., 113, 173, 10.1016/0165-1161(83)90010-9 Reddy, 1987, Carcinogenesis of the colon and rectum, 326 Phillips, 1973, Dye exclusion tests for cell viability, 406 Rao, 1991, Effect of oltipraz [5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione] on azoxymethane-induced biochemical changes related to early colon carcinogenesis in male F344 rats, 197, 77 Braun, 1984, Synthetic tyrosine as substrates and inhibitors of tyrosine-specific kinases, J. Biol. Chem., 259, 2051, 10.1016/S0021-9258(17)43311-4 Huang, 1985, Inhibition of mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by tannic acid, hydroxylated anthraquinones and hydroxylated cinnamic acid derivatives, Carcinogenesis, 6, 237, 10.1093/carcin/6.2.237 Chan, 1986, Mechanism of inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced mutagenesis by phenolic compounds, Cancer Lett., 31, 27, 10.1016/0304-3835(86)90163-1 Fung, 1988, Mutagenic activity of some coffee flavor ingredients, Mutat. Res., 204, 219, 10.1016/0165-1218(88)90092-4 Mulky, 1987, Antimutagenicity of crucumins and related compound: the structural requirement for the antimutagenicity of crucumins, Indian Drugs, 25, 91 Francis, 1989, Modification of the mutagenicity of aflatoxin B1 and N-methyl-N′-nitro-N-nitrosoguanidine by certain phenolic compounds, Cancer Lett., 45, 177, 10.1016/0304-3835(89)90074-8 Mori, 1986, Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters, Cancer Lett., 30, 49, 10.1016/0304-3835(86)90131-X Umezawa, 1990, Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors, FEBS, 260, 198, 10.1016/0014-5793(90)80102-O Su, 1991, Suppression of adenovirus Type 5 EIA-mediated transformation and expression of the transformed phenotype by caffeic acid phenethylester (CAPE), Mol. Carcino, 4, 231, 10.1002/mc.2940040310 Reddy, 1990, Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflam-matory drug, with D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet, Cancer Res., 50, 2562 Frenkel, 1992, Inhibition of tumor promoter-mediated oxidative processes by caffeic acid phenethyl ester (CAPE), 83, 967 Levitzki, 1991, Inhibition of protein tyrosine kinases by tyrphostins, Methods Enzymol., 201, 347, 10.1016/0076-6879(91)01031-V Umazawa, 1986, Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstain, produced by MH435-hF3, J. Antibiot., 39, 170, 10.7164/antibiotics.39.170 Gazit, 1989, Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors, J. Med. Chem., 32, 2344, 10.1021/jm00130a020 Imoto, 1987, Antitumor activity of erbstatin, a tyrosine protein kinase inhibitor, Jpn. J. Cancer Res., (Gann), 78, 329